UNSPSC 51434956: Quinethazone/reserpine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434956 Quinethazone/reserpine is a Commodity code tracking pharmaceutical products, though state and local governments procuring under it are actually sourcing emergency medical medications rather than the specific antihypertensive agents the code nominally describes. The scope of work consists of acquiring finished pharmaceutical products — typically injectables and vials — for use by public safety and emergency medical services. Issuing bodies include municipal fire departments and city purchasing departments buying on behalf of emergency response operations.

The City of Tampa's Purchasing Department posted an IFB in April 2026 for Advanced Life Support Medications (Solicitation 26P00188) on behalf of Tampa Fire Rescue, requesting 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with delivery required within ten calendar days and a nine-month minimum expiration guarantee at acceptance. The bid was due April 8, 2026, with the estimated contract value of $40,000.00 awarded to the lowest responsive, responsible bidder on a one-year term plus two optional one-year renewals. The solicitation carried a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount, not to exceed $10,000, and required vendors to submit Safety Data Sheets compliant with OSHA Hazard Communication Standards and comprehensive accessibility documentation under WCAG 2.2 Level AA and Section 508 standards. This activity is concentrated in Florida, with recent opportunity flow limited to municipal emergency services procurement.